FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008014733> ?p ?o ?g. }

• W2008014733 endingPage "13" @default.
• W2008014733 startingPage "8" @default.
• W2008014733 abstract "To review the efficacy of inhibitors of matrix metalloproteinase-9, corticosteroids, and doxycycline for treatment of recalcitrant recurrent corneal erosion.Retrospective, clinic-based, interventional case series. The medical records of seven consecutive patients who were treated between January 1995 to January 2000 for recurrent corneal erosion who had not responded to conventional therapy were reviewed. Treatment of seven eyes of seven patients consisted of oral doxycycline (50 mg, two times a day) for 2 months along with a topical corticosteroid (either methylprednisolone 1%, prednisolone acetate 1%, or fluoromethalone 0.1%) three times a day, for 2 to 3 weeks. The effects of doxycycline and methylprednisolone on metalloproteinase-9 activity in human corneal epithelial cultures were evaluated by gelatin zymography and a commercial metalloproteinase-9 activity assay kit.Fingernail injury in three of the seven eyes was the most common form of corneal injury. There was no evidence of epithelial basement membrane or corneal stromal dystrophy in any of the patients, although epithelial microcysts were observed in the involved area in three patients. One eye had intact elevated corneal epithelium that showed abnormal diffuse staining with fluorescein dye, and six eyes had a corneal epithelial defect at the time of presentation. In all seven eyes, pain resolved and epithelial defects healed within 2 to 10 days after initiation of therapy. No recurrence was observed during an average follow-up period of 21.9 months (range, 1.5 to 60 months). Methylprednisolone and doxycycline each produced a statistically significant decrease in amount and activity of metalloproteinase-9 in conditioned media of human corneal epithelial cultures.Therapy with a combination of medications that inhibit metalloproteinase-9 produced rapid resolution and prevented further recurrence of cases of recurrent corneal erosions that were unresponsive to conventional therapies." @default.
• W2008014733 created "2016-06-24" @default.
• W2008014733 creator A5048114543 @default.
• W2008014733 creator A5061055046 @default.
• W2008014733 creator A5081501369 @default.
• W2008014733 creator A5086607086 @default.
• W2008014733 date "2001-07-01" @default.
• W2008014733 modified "2023-10-14" @default.
• W2008014733 title "Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids" @default.
• W2008014733 cites W1973254258 @default.
• W2008014733 cites W1980480613 @default.
• W2008014733 cites W1985101546 @default.
• W2008014733 cites W1986620171 @default.
• W2008014733 cites W1994875486 @default.
• W2008014733 cites W1996413321 @default.
• W2008014733 cites W2022300500 @default.
• W2008014733 cites W2029971288 @default.
• W2008014733 cites W2032192840 @default.
• W2008014733 cites W2059515600 @default.
• W2008014733 cites W2063934495 @default.
• W2008014733 cites W2070216170 @default.
• W2008014733 cites W2086421659 @default.
• W2008014733 cites W2087810607 @default.
• W2008014733 cites W2109658199 @default.
• W2008014733 cites W2135427416 @default.
• W2008014733 cites W2136908636 @default.
• W2008014733 cites W2153055943 @default.
• W2008014733 cites W2284389943 @default.
• W2008014733 cites W2320349682 @default.
• W2008014733 cites W4235095409 @default.
• W2008014733 cites W4242085988 @default.
• W2008014733 cites W57283754 @default.
• W2008014733 cites W2146531377 @default.
• W2008014733 doi "https://doi.org/10.1016/s0002-9394(01)00913-8" @default.
• W2008014733 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11438047" @default.
• W2008014733 hasPublicationYear "2001" @default.
• W2008014733 type Work @default.
• W2008014733 sameAs 2008014733 @default.
• W2008014733 citedByCount "201" @default.
• W2008014733 countsByYear W20080147332012 @default.
• W2008014733 countsByYear W20080147332013 @default.
• W2008014733 countsByYear W20080147332014 @default.
• W2008014733 countsByYear W20080147332015 @default.
• W2008014733 countsByYear W20080147332016 @default.
• W2008014733 countsByYear W20080147332017 @default.
• W2008014733 countsByYear W20080147332018 @default.
• W2008014733 countsByYear W20080147332019 @default.
• W2008014733 countsByYear W20080147332020 @default.
• W2008014733 countsByYear W20080147332021 @default.
• W2008014733 countsByYear W20080147332022 @default.
• W2008014733 countsByYear W20080147332023 @default.
• W2008014733 crossrefType "journal-article" @default.
• W2008014733 hasAuthorship W2008014733A5048114543 @default.
• W2008014733 hasAuthorship W2008014733A5061055046 @default.
• W2008014733 hasAuthorship W2008014733A5081501369 @default.
• W2008014733 hasAuthorship W2008014733A5086607086 @default.
• W2008014733 hasConcept C109523444 @default.
• W2008014733 hasConcept C118487528 @default.
• W2008014733 hasConcept C126322002 @default.
• W2008014733 hasConcept C141071460 @default.
• W2008014733 hasConcept C2775958869 @default.
• W2008014733 hasConcept C2776715498 @default.
• W2008014733 hasConcept C2776882836 @default.
• W2008014733 hasConcept C2777179404 @default.
• W2008014733 hasConcept C2779257441 @default.
• W2008014733 hasConcept C2780372218 @default.
• W2008014733 hasConcept C501593827 @default.
• W2008014733 hasConcept C71924100 @default.
• W2008014733 hasConcept C86803240 @default.
• W2008014733 hasConcept C89423630 @default.
• W2008014733 hasConceptScore W2008014733C109523444 @default.
• W2008014733 hasConceptScore W2008014733C118487528 @default.
• W2008014733 hasConceptScore W2008014733C126322002 @default.
• W2008014733 hasConceptScore W2008014733C141071460 @default.
• W2008014733 hasConceptScore W2008014733C2775958869 @default.
• W2008014733 hasConceptScore W2008014733C2776715498 @default.
• W2008014733 hasConceptScore W2008014733C2776882836 @default.
• W2008014733 hasConceptScore W2008014733C2777179404 @default.
• W2008014733 hasConceptScore W2008014733C2779257441 @default.
• W2008014733 hasConceptScore W2008014733C2780372218 @default.
• W2008014733 hasConceptScore W2008014733C501593827 @default.
• W2008014733 hasConceptScore W2008014733C71924100 @default.
• W2008014733 hasConceptScore W2008014733C86803240 @default.
• W2008014733 hasConceptScore W2008014733C89423630 @default.
• W2008014733 hasIssue "1" @default.
• W2008014733 hasLocation W20080147331 @default.
• W2008014733 hasLocation W20080147332 @default.
• W2008014733 hasOpenAccess W2008014733 @default.
• W2008014733 hasPrimaryLocation W20080147331 @default.
• W2008014733 hasRelatedWork W1978903987 @default.
• W2008014733 hasRelatedWork W2003000654 @default.
• W2008014733 hasRelatedWork W2008014733 @default.
• W2008014733 hasRelatedWork W2038981906 @default.
• W2008014733 hasRelatedWork W2110640592 @default.
• W2008014733 hasRelatedWork W2111359070 @default.
• W2008014733 hasRelatedWork W2125408053 @default.
• W2008014733 hasRelatedWork W2374915814 @default.
• W2008014733 hasRelatedWork W27342760 @default.

• next